Rheumatology Advance Access first published online on June 21, 2005
This version published online on September 8, 2005
Rheumatology, doi:10.1093/rheumatology/keh723
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
* To whom correspondence should be addressed. Objective. To assess the prevalence, characteristics and prognostic factors of interstitial lung disease (ILD) in Korean patients with polymyositis (PM), dermatomyositis (DM) and amyopathic dermatomyositis (ADM). Methods. We reviewed the medical records of 72 consecutive PM and DM patients, including six patients with ADM, who were seen at the Rheumatology Clinic of Seoul National University Hospital between 1984 and 2003. Results. Twenty-nine PM/DM patients (40.3%) developed ILD. Anti-Jo-1 antibody and arthralgia were associated with the presence of ILD (P = 0.022 and P = 0.041, respectively), whereas dysphagia was more frequently found in patients without ILD (P = 0.041). Lung biopsies revealed diffuse alveolar damage (DAD) (n = 2), usual interstitial pneumonia (UIP) with DAD (n = 2), UIP (n = 1), and non-specific interstitial pneumonia (n = 2). Of the 29 patients, 11 (37.9%) died. The mean survival time in ILD patients was significantly shorter than in those without ILD (13.8±1.8 vs 19.2±0.9 yr, P = 0.017). Poor survival in ILD patients was associated with a Hamman-Rich-like presentation (P = 0.0000), ADM features (P = 0.0001) and an initial forced vital capacity (FVC) Conclusions. ILD was observed in 40.3% of Korean PM/DM patients and was associated with poor survival. A Hamman-Rich-like presentation, ADM features and an initial FVC
Received December 10, 2004
Accepted May 20, 2005
Concise Report
Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis
2 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Clinical Research Institute, Seoul National University Hospital, Seoul, Korea
3 Department of Pathology, Seoul National University College of Medicine, Seoul, Korea; Clinical Research Institute, Seoul National University Hospital, Seoul, Korea
E. B. Lee, E-mail: leb7616{at}snu.ac.kr
![]()
Abstract
60% (P = 0.024).
60% were associated with poor survival in ILD.
This is a new version of this paper as an acknowledgement has been added.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Gunawardena, Z. E. Betteridge, and N. J. McHugh Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression Rheumatology, June 1, 2009; 48(6): 607 - 612. [Abstract] [Full Text] [PDF] |
||||
